Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 25 for “"Finasteride"”.
-
Finasteride lowers cholesterol in humans and delays atherosclerosis progression in Ldlr-/- mice
Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2023-12-01
-
EFFECT OF FINASTERIDE TREATMENT IN MALE RAT: DEPRESSIVE-LIKE BEHAVIOR AND RELATED PARAMETERS
… of the treatment for androgenetic alopecia with finasteride, an inhibitor of the enzyme 5α-R. Thus, these patients are affected by the so-called post-finasteride syndrome (PFS). Interestingly, suspension of finasteride treatment did not only lead, as expected, to an alteration of 5α-reduced …
-
The impact of minoxidil on male reproductive biology: a multi-approach study including systematic review, in vivo, and ex vivo experiments
… in both men and women. It is often combined with finasteride, which targets androgen metabolism, to enhance therapeutic efficacy. While minoxidil is commonly used, its pharmacodynamic mechanisms are not fully understood. The prevailing theory is that minoxidil works through vasodilation and …
-
Chronic exposures to the herbicide atrazine and the pharmaceutical finasteride disrupt sex steroid and thyroid hormone signalling and gonadal development in frogs
… frog) early development. The prostate drug finasteride (a 5alpha-reductase type 2 and srd5beta inhibitor in humans) was used in short-term (25, 50 and 100 muM) and chronic (25 muM) exposures of S. tropicalis under laboratory conditions. Finasteride inhibited srd5beta and aromatase (cyp19) …
-
Η επίδραση της χορήγησης φιναστερίδης στην αγγείωση του προστάτη
… of the present study is to assess the effects of finasteride on angiogenetic and hypoxia markers in benign prostatic hyperplasia (BPH). Our material consisted of one hundred and seventy eight patients aged 51-85 years (mean 68.7), suffering from BPH and awaiting treatment by transurethral prostate …
-
Progesterone and its Metabolites: Anticonvulsant and Behavioral Studies
… THP (1-30 mg/kg), progesterone (100 mg/kg) with finasteride (50 mg/kg), as well as finasteride alone (50 mg/kg), the anticonvulsant drugs carbamazepine (50 mg/kg) and midazolam (2 mg/kg). DHP was not anticonvulsant, whereas THP was anticonvulsant at sedative doses. Surprisingly, high doses of …
-
Metabolic effects of 5α-reductase inhibition in humans
… are designated 5αR1 and 5αR2. Inhibitors of 5αR, finasteride (a 5αR2 inhibitor) and dutasteride (a dual 5αR1 and 5αR2 inhibitor), are utilised in conditions where a reduction in androgen action is desired, including benign prostatic hyperplasia. Although 5αR2 is predominantly expressed in …
-
Effects of 5alpha-androstane-3alpha,17beta-diol (3alpha diol) on Attention and Cortical Dendritic Morphology in the 3xTg Mouse Model of Alzheimer’s Disease
… its mechanisms remain largely uncharacterized. Finasteride, a 5α-reductase inhibitor, has been associated with multiple long-lasting, adverse effects. As 5α-reduced metabolites may be critical in regulating neuroprotective effects of circulating steroids in the brain, the studies presented …
-
5α-reductase isoenzymes mediate stress-exacerbated Tourette-like responses in animal models
… 3α, 5α steroids with the 5α-reductase inhibitor finasteride reduces tics in adult male patients with Tourette syndrome; however, the mechanism of action is largely unidentified. In this dissertation, the mechanism by which stress exacerbates Tourette syndrome symptoms and finasteride attenuates …
-
Successes and failures of evidence based urology
… of the Phase III clinical trials of finasteride which I undertook, demonstrated that this drug was effective only in men with enlarged prostates and justified the biological approach taken in the development of this drug which was an inhibitor of 5-alpha reductase, the enzyme which …
-
Combination of Dietary Tomato and Broccoli Powders Are Effective Growth Inhibitors of Dunning R3327-H Prostate Adenocarcinomas
… quantified in the liver, prostate, and tumors. Finasteride significantly decreased expression of 5-alpha-reductase-II, Bcl-2, and IL-6 in tumors. IL-6 was reduced in high lycopene and broccoli, P=0.05, and TNF-alpha was lower with low lycopene, P=0.05. Overall, the combination of tomato and …
-
Mechanisms and treatments of drug consumption: A preclinical exploration in harm reducing pharmacotherapies for substance use disorders
… and opioid use. Another FDA approved drug, finasteride, has shown promise in decreasing gambling disorders in people living with Parkinson’s and decreases ticks in people living with Tourette’s. Because it is known that both of these disease have heavily disrupted dopamine signaling we were …
-
Testosterone’s regulation of the HPA axis differs for adolescent and adult male rats
… treated with fadrozole (aromatase inhibitor), finasteride (5a-reductase inhibitor), flutamide (androgen receptor antagonist), or vehicle (VEH). Higher CORT concentrations after restraint were found in P45 than in P75 only among VEH rats. Among P45 rats, CORT levels were higher in VEH than in …
-
STRATEGIES AGAINST ANDROGENETIC ALOPECIA THROUGH IN-VITRO COMPOUND SCREENING AND THREE-DIMENSIONAL HAIR FOLLICLE ENGINEERING
The use of Minoxidil and Finasteride for Androgenetic alopecia (AGA) are often challenging in areas of safety and efficacy. Current strategies against AGA relies on identifying safer and more efficacious compounds and the culturing of 3-dimensional (3D) hair follicle-like cultures. We examined six …
-
Regulation of the metabolic phenotype of human hepatocytes by glucocorticoids and androgens
… inhibition using the 5αR inhibitors finasteride and dutasteride, augmented cortisol action. We have demonstrated that manipulation of 5αR2 activity can regulate lipogenesis in human hepatocytes in vitro. This may have significant clinical implications for those patients prescribed 5αR …
-
Ruolo dei neurosteroidi nella modulazione dopaminergica
… antidopaminergic effects. The 5AR inhibitor, finasteride (FIN), is currently approved for the therapy of benign prostatic hyperplasia and androgenic alopecia. We found that, in rodents, FIN attenuates the severity of behavioral manifestations induced by dopaminergic agents, including deficits …
-
The effects of progestins on animal models of cocaine bingeing and relapse.
… of PROG's effects was further studied by using finasteride, a 5-alpha reductase inhibitor that prevents the metabolism of PROG into ALLO. Finasteride (FIN) was administered concurrently with PROG to determine whether it could block the attenuating effects of PROG on cocaine-primed reinstatement, …
-
Development of a novel, clinically-relevant model for investigating factors that stimulate human hair growth
… unlike the 5¿-reductase type 2 inhibitor finasteride (40ng/ml). Immunohistochemistry demonstrated androgen receptor and 5¿-reductase type 2 proteins in both follicle types, while quantitative real-time PCR and gene microarray analysis detected their increased gene expression in …
-
Hair Regeneration : A Multi-Targeting Approach Using a Botanical-Vitamin-Mineral Compound in the Treatment of Hair Loss
… 18.37*, Viviscal: 13.23, Minoxidil 5%: 13.13*, Finasteride: 12.38, and Minoxidil 2%: 10.54. BVM regrowth rates were linear in men, accelerating in women. 99% of the BVM TH regrowth in women was derived from dormant HFs. In men, TH regrowth was 50/50 from inactive HFs / vellus-like hair. All …
Page 1 of 2